Quadrant Capital Group LLC Cv Rx, Inc. Transaction History
Quadrant Capital Group LLC
- $2.65 Billion
- Q1 2025
A detailed history of Quadrant Capital Group LLC transactions in Cv Rx, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 95 shares of CVRX stock, worth $564. This represents 0.0% of its overall portfolio holdings.
Number of Shares
95Holding current value
$564% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CVRX
# of Institutions
99Shares Held
16.3MCall Options Held
53.4KPut Options Held
32.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$24.4 Million16.67% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$12 Million2.35% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT1.23MShares$7.3 Million1.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.01MShares$5.98 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$5.2 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $122M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...